Global Consumer Healthcare Market 2026-2030

Description

The global consumer healthcare market is forecasted to grow by USD 205.3 bn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global consumer healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by awareness about lifestyle diseases, increase in self-medication practices, growth of geriatric population is augmenting market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	6.7%
CAGR	7.2%
Incremental Value	$205.3 bn

Technavio's global consumer healthcare market is segmented as below:

By Product

OTC pharmaceuticals
Dietary supplements

By Distribution Channel

Offline
Online

By Therapeutic Area

Pain relief and analgesics
Digestive health and gastrointestinal
Cold and flu
Skin care
Others

Geography

North America
- US
- Canada
- Mexico
Asia
Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
Rest of World (ROW)
Rest of World (ROW)

This study identifies the accelerated use of online resources in global consumer healthcare market as one of the prime reasons driving the global consumer healthcare market growth during the next few years. Also, promotions and marketing initiatives by market companies and strategic alliances among market companies will lead to sizable demand in the market.

The report on the global consumer healthcare market covers the following areas:

Global consumer healthcare market sizing
Global consumer healthcare market forecast
Global consumer healthcare market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global consumer healthcare market vendors that include Abbott Laboratories, Bausch Lomb Corp., Bayer AG, Church and Dwight Co. Inc., Cipla Inc., Dr. Reddys Laboratories Ltd., Glanbia plc, Glenmark Pharmaceuticals Ltd., Haleon Plc, Herbalife International Inc., Jamieson Wellness Inc., Kenvue Inc., Krka d.d., Perrigo Co. Plc, Prestige Consumer Healthcare, Reckitt Benckiser Group Plc, Sanofi SA, STADA Arzneimittel AG, Sun Pharmaceutical Industries, The Himalaya Drug Co.. Also, the global consumer healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73381

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Consumer Healthcare Market 2020 - 2024
- Historic Market Size - Data Table on Global Consumer Healthcare Market 2020 - 2024 ($ billion)
5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ billion)
5.3 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ billion)
5.4 Therapeutic Area segment analysis 2020 - 2024
- Historic Market Size - Therapeutic Area Segment 2020 - 2024 ($ billion)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ billion)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI on Global Consumer Healthcare Market
6.2 Impact of Geopolitical Conflicts on Global Consumer Healthcare Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Product

8.1 Market segments
8.2 Comparison by Product
8.3 OTC pharmaceuticals - Market size and forecast 2025-2030
8.4 Dietary supplements - Market size and forecast 2025-2030
8.5 Market opportunity by Product
- Market opportunity by Product ($ billion)

9 Market Segmentation by Distribution Channel

9.1 Market segments
9.2 Comparison by Distribution Channel
9.3 Offline - Market size and forecast 2025-2030
9.4 Online - Market size and forecast 2025-2030
9.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ billion)

10 Market Segmentation by Therapeutic Area

10.1 Market segments
10.2 Comparison by Therapeutic Area
10.3 Pain relief and analgesics - Market size and forecast 2025-2030
10.4 Digestive health and gastrointestinal - Market size and forecast 2025-2030
10.5 Cold and flu - Market size and forecast 2025-2030
10.6 Skin care - Market size and forecast 2025-2030
10.7 Others - Market size and forecast 2025-2030
10.8 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Asia - Market size and forecast 2025-2030
- 12.4.1 China - Market size and forecast 2025-2030
- 12.4.2 India - Market size and forecast 2025-2030
- 12.4.3 Japan - Market size and forecast 2025-2030
- 12.4.4 South Korea - Market size and forecast 2025-2030
- 12.4.5 Indonesia - Market size and forecast 2025-2030
- 12.4.6 Thailand - Market size and forecast 2025-2030
12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 France - Market size and forecast 2025-2030
- 12.5.3 UK - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 Argentina - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Awareness about lifestyle diseases
- Increase in self-medication practices
- Growth of geriatric population is augmenting market growth
13.2 Market challenges
- Lack of corroborative studies on dietary supplements
- Adverse effects of OTC medications
- Widespread presence of counterfeit pharmaceuticals
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Accelerated use of online resources in global consumer healthcare market
- Promotions and marketing initiatives by market companies
- Strategic alliances among market companies

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Bausch Lomb Corp.
- Bausch Lomb Corp. - Overview
- Bausch Lomb Corp. - Business segments
- Bausch Lomb Corp. - Key news
- Bausch Lomb Corp. - Key offerings
- Bausch Lomb Corp. - Segment focus
- SWOT
15.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.7 Church and Dwight Co. Inc.
- Church and Dwight Co. Inc. - Overview
- Church and Dwight Co. Inc. - Business segments
- Church and Dwight Co. Inc. - Key offerings
- Church and Dwight Co. Inc. - Segment focus
- SWOT
15.8 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
15.9 Dr. Reddys Laboratories Ltd.
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
15.10 Glanbia plc
- Glanbia plc - Overview
- Glanbia plc - Business segments
- Glanbia plc - Key offerings
- Glanbia plc - Segment focus
- SWOT
15.11 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key news
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
15.12 Haleon Plc
- Haleon Plc - Overview
- Haleon Plc - Business segments
- Haleon Plc - Key offerings
- Haleon Plc - Segment focus
- SWOT
15.13 Perrigo Co. Plc
- Perrigo Co. Plc - Overview
- Perrigo Co. Plc - Business segments
- Perrigo Co. Plc - Key offerings
- Perrigo Co. Plc - Segment focus
- SWOT
15.14 Prestige Consumer Healthcare
- Prestige Consumer Healthcare - Overview
- Prestige Consumer Healthcare - Business segments
- Prestige Consumer Healthcare - Key offerings
- Prestige Consumer Healthcare - Segment focus
- SWOT
15.15 Reckitt Benckiser Group Plc
- Reckitt Benckiser Group Plc - Overview
- Reckitt Benckiser Group Plc - Business segments
- Reckitt Benckiser Group Plc - Key offerings
- Reckitt Benckiser Group Plc - Segment focus
- SWOT
15.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
15.17 STADA Arzneimittel AG
- STADA Arzneimittel AG - Overview
- STADA Arzneimittel AG - Business segments
- STADA Arzneimittel AG - Key offerings
- STADA Arzneimittel AG - Segment focus
- SWOT
15.18 Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations